Company Overview of Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci. &Tech. Co., Ltd., a biopharmaceutical company, develops, manufactures, and commercializes bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. The company develops Neucardin, an anti-heart failure drug; Recombinant Human Neuregulin-1 that is used in the treatment of heart failure; and recombinant human ErbB3 fragment, a therapeutic tumor vaccine to treat cancer. Zensun (Shanghai) Sci. &Tech. Co., Ltd. is based in Shanghai, China. It has subsidiaries in the United States and Australia.
Pudong Zhangjiang Hi-Tech Park Curie Road 68
86 21 5080 2627
86 21 5080 2621
Key Executives for Zensun (Shanghai) Sci & Tech Co., Ltd.
Similar Private Companies By Industry
|3D BioOptima Co. Ltd.||Asia|
|Adagene (Suzhou) Limited||Asia|
|AGCU ScienTech Incorporation||Asia|
|Anhui Dongfang Xinxin Biotechnology Co., Ltd.||Asia|
|Anhui Life Co.,Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Zensun (Shanghai) Sci & Tech Co., Ltd., please visit www.zensun.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.